Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermalab is a South Korean biotechnology company specializing in the research, development, and manufacture of high-quality bioactive ingredients for the cosmetic and personal care industries. Founded in 2003, the company utilizes advanced extraction, fermentation, and bio-conversion technologies to produce natural extracts, peptides, and functional materials. Dermalab focuses on providing innovative solutions for skin health, including anti-aging, whitening, and anti-inflammatory agents. The company operates a dedicated R&D center and GMP-compliant manufacturing facilities to serve a global clientele of cosmetic brands. Their portfolio includes a wide range of plant-derived substances and bio-mimetic components designed to enhance the efficacy of topical formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dermalab.